Search

Your search keyword '"*LACIDIPINE"' showing total 683 results

Search Constraints

Start Over You searched for: Descriptor "*LACIDIPINE" Remove constraint Descriptor: "*LACIDIPINE"
683 results on '"*LACIDIPINE"'

Search Results

1. Lacidipine Inhibits NF-κB and Notch Pathways and Mitigates DSS-Induced Colitis.

2. Lacidipine, thiamine pyrophosphate and their combination on the ocular ischemic syndrome induced by bilateral common carotid artery ligation

3. Effects of adenosine triphosphate, Lacidipine, and Benidipine on 5-fluorouracil-induced kidney damage in rats.

4. Anti-inflammatory, Analgesic, and Gastric Tissue Effects of Lacidipine, Aspirin, and Their Combination

5. Formulation and Characterization of Nanoparticulate Drug Carrier System for Lacidipine.

6. Oral Gastroretentive Film of Lacidipine for the Treatment of Gastroparesis.

7. Formulation and characterisation of lacidipine niosomal gel for transdermal delivery.

8. Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism.

9. [Accurate determination of three new antihypertensive drugs illegally added to food using ultra-high performance liquid chromatography-tandem mass spectrometry].

11. A Novel High Content Angiogenesis Assay Reveals That Lacidipine, L-Type Calcium Channel Blocker, Induces In Vitro Vascular Lumen Expansion.

12. Formulation of Lipid-Based Nanocarriers of Lacidipine for Improvement of Oral Delivery: Box-Behnken Design Optimization, In Vitro, Ex Vivo, and Preclinical Assessment.

13. Formulation and Investigation of Lacidipine as a Nanoemulsions

14. Lacidipine Attenuates Symptoms of Nicotine Withdrawal in Mice.

15. Lacidipine Ameliorates the Endothelial Senescence and Inflammatory Injury Through CXCR7/P38/C/EBP-β Signaling Pathway

16. Lacidipine Prevents Scopolamine-Induced Memory Impairment by Reducing Brain Oxido-nitrosative Stress in Mice.

17. Fabrication, optimization, and evaluation of lyophilized lacidipine-loaded fatty-based nanovesicles as orally fast disintegrating sponge delivery system.

18. Ternary solid dispersions of lacidipine: Enhancing dissolution and supersaturation maintenance through strategic formulation optimization.

20. Lacidipine, thiamine pyrophosphate and their combination on the ocular ischemic syndrome induced by bilateral common carotid artery ligation.

21. Beneficial effects of combined therapy with lacidipine and candesartan in obese hypertensive patients

22. Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study

23. Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs

24. Lacidipine attenuates reserpine-induced depression-like behavior and oxido-nitrosative stress in mice.

25. Synergetic effect of nucleation and crystal growth inhibitor on in vitro-in vivo performance of supersaturable lacidipine solid dispersion.

26. Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability.

27. Analytical lifecycle management approach: Application to development of a reliable LC method for estimation of lacidipine.

28. Lacidipine Attenuates Symptoms of Nicotine Withdrawal in Mice

29. Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study.

30. Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability.

31. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.

32. An Overview on Estimation of Lacidipine from Bulk and Formulation

33. Analytical Methods of Dihydropyridines Based Calcium Channel Blockers - Amlodipine, Lacidipine, Isradipine, Nifedipine, Felodipine, Cilnidipine and its related formulations: A Review

34. Degradation Studies of Lacidipine: Identification, Isolation and Structural Characterization of Stress Degradation Products using LCMS, Mass mediated Prep-HPLC, NMR and HRMS

35. A Novel High Content Angiogenesis Assay Reveals That Lacidipine, L-Type Calcium Channel Blocker, Induces In Vitro Vascular Lumen Expansion

36. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.

37. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.

38. Solubility of Nifedipine and Lacidipine in Supercritical CO: Measurement and Correlation.

39. Carbon microspheres uniformly decorated with ceria nanoparticles as an ultrasensitive platform for electrochemical sensing of antihypertensive drug lacidipine in patient plasma and pharmaceutical formulation.

41. Lacidipine Attenuates Apoptosis via a Caspase-3 Dependent Pathway in Human Kidney Cells

42. Real and potential benefits of third-generation calcium antagonists

43. Formulation and Investigation of Lacidipine as a Nanoemulsions

47. Simultaneous Estimation of Metoprolol Succinate and Lacidipine in Binary Combination using High Performance Liquid Chromatographic Method.

48. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2 factorial design and in vivo evaluation in rabbits.

49. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.

50. Lacidipine self-nanoemulsifying drug delivery system for the enhancement of oral bioavailability.

Catalog

Books, media, physical & digital resources